Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    "methodist hospital" | Open Studies | "Thrombosis" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Not yet recruiting Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
Conditions: Pulmonary Embolism;   Venous Thrombosis
Interventions: Drug: Enteric Coated Aspirin;   Drug: Warfarin;   Drug: Rivaroxaban
2 Recruiting A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Condition: Acute Coronary Syndromes
Interventions: Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
3 Recruiting Cook IVC Filter Study
Condition: Pulmonary Embolism
Intervention: Device: Günther Tulip® Vena Cava Filter and Cook Celect® Vena Cava Filters
4 Recruiting ABSORB III Randomized Controlled Trial (RCT)
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE
5 Recruiting Absorb IV Randomized Controlled Trial
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE

Study has passed its completion date and status has not been verified in more than two years.